Latest Research | Long Covid
Latest long COVID research explores persistent symptoms, underlying mechanisms, and potential treatments. Studies reveal multi-system impacts, including cardiovascular, neurological, and respiratory issues. Researchers are investigating biomarkers for diagnosis and effective therapeutic interventions. Emerging data suggest the importance of vaccination in reducing long COVID risk. Ongoing trials aim to identify targeted therapies to alleviate prolonged symptoms and improve patient outcomes.
A Day in the Life of a Longhauler”, a photo-based project that aims to highlight the daily realities of those living with Long COVID symptoms. This project is made possible via researchers at Simon Fraser University, in partnership with the Museum of Vancouver (MoV) and the PHSA Post-COVID-19 Interdisciplinary Clinical Care Network (PCICCN)].
E28 Join Professor David Petrino as he delves into groundbreaking long COVID treatments, including repurposed HIV antivirals, patient phenotyping, and the innovative Cohen Center's hybrid approach to care and research for chronic illnesses.
Breaking News Prof Todd Davenport Edits the January edition of CPTJ Dedicated to Long COVID Rehabilitation
PROFESSOR KLIMAS HAS FDA APPROVAL FOR MONOCLONAL ANTIBODY RESEARCH!
E27: Dr. David Putrino discusses the hormonal and neurological impacts of Long COVID, highlighting key research findings, symptom patterns, and emerging treatments through innovative therapies and clinical trials.
E26: Explore cutting-edge research on Long COVID and ME/CFS with Dr. Nancy Klimas, uncovering innovative treatments, immune system insights, and the transformative potential of holistic healthcare approaches.
E25: Explore Mast Cell Activation Syndrome (MCAS) with Dr. Funmi Okunola and Dr. David L. Kaufman. Uncover diagnostic challenges, innovative treatments, and expert insights to transform patient care. Tune in now!
E23 In this episode, the Post COVID Long-term Recovery Collaborative (PLRC) members Lisa McCorkell, Gina Assaf, and Letícia Soares discuss their work supporting long COVID patients and advocating for better healthcare responses.
PROFESSOR KLIMAS HAS FDA APPROVAL FOR MONOCLONAL ANTIBODY RESEARCH!
E23 Join Prof Nancy Klimas to discover groundbreaking insights into Long COVID treatments! Explore how monoclonal antibodies offer hope by targeting viral persistence and spike proteins. Learn from leading experts shaping the future of recovery and resilience.
